135 related articles for article (PubMed ID: 853365)
1. Dissolution rates of corticosteroids utilizing sugar glass dispersions.
Allen LV; Yanchick VA; Maness DD
J Pharm Sci; 1977 Apr; 66(4):494-7. PubMed ID: 853365
[TBL] [Abstract][Full Text] [Related]
2. Dissolution rates of hydrocortisone and prednisone utilizing sugar solid dispersion systems in tablet form.
Allen LV; Levinson RS; Martono DD
J Pharm Sci; 1978 Jul; 67(7):979-81. PubMed ID: 660521
[TBL] [Abstract][Full Text] [Related]
3. Development of prednisone:polyethylene glycol 6000 fast-release tablets from solid dispersions: solid-state characterization, dissolution behavior, and formulation parameters.
Leonardi D; Barrera MG; Lamas MC; Salomón CJ
AAPS PharmSciTech; 2007 Dec; 8(4):E108. PubMed ID: 18181529
[TBL] [Abstract][Full Text] [Related]
4. [On the effect of corticosteroids and other inflammation-inhibiting substances].
Wilbrandt W
Schweiz Med Wochenschr; 1966 Sep; 96(35):1136-44. PubMed ID: 5995225
[No Abstract] [Full Text] [Related]
5. Dissolution rates of sulfamethoxazole utilizing sugar glass dispersions.
Ghanem A; Meshali M; Ibraheem Y
J Pharm Pharmacol; 1980 Oct; 32(10):675-7. PubMed ID: 6107338
[TBL] [Abstract][Full Text] [Related]
6. Fusion production of solid dispersions containing a heat-sensitive active ingredient by hot melt extrusion and Kinetisol dispersing.
Dinunzio JC; Brough C; Hughey JR; Miller DA; Williams RO; McGinity JW
Eur J Pharm Biopharm; 2010 Feb; 74(2):340-51. PubMed ID: 19818402
[TBL] [Abstract][Full Text] [Related]
7. Anomalous dissolution behaviour of tablets prepared from sugar glass-based solid dispersions.
van Drooge DJ; Hinrichs WL; Frijlink HW
J Control Release; 2004 Jul; 97(3):441-52. PubMed ID: 15212876
[TBL] [Abstract][Full Text] [Related]
8. [PRINCIPLES OF CORTISONE THERAPY].
KAISER H
Urologe; 1963 Jul; 2():203-10. PubMed ID: 14047047
[No Abstract] [Full Text] [Related]
9. Improved dissolution behavior of lipophilic drugs by solid dispersions: the production process as starting point for formulation considerations.
Srinarong P; de Waard H; Frijlink HW; Hinrichs WL
Expert Opin Drug Deliv; 2011 Sep; 8(9):1121-40. PubMed ID: 21722000
[TBL] [Abstract][Full Text] [Related]
10. A comparative study of spray-dried and freeze-dried hydrocortisone/polyvinyl pyrrolidone solid dispersions.
Dontireddy R; Crean AM
Drug Dev Ind Pharm; 2011 Oct; 37(10):1141-9. PubMed ID: 21615280
[TBL] [Abstract][Full Text] [Related]
11. Review: physical chemistry of solid dispersions.
Janssens S; Van den Mooter G
J Pharm Pharmacol; 2009 Dec; 61(12):1571-86. PubMed ID: 19958579
[TBL] [Abstract][Full Text] [Related]
12. Preparation of a solid dispersion of felodipine using a solvent wetting method.
Kim EJ; Chun MK; Jang JS; Lee IH; Lee KR; Choi HK
Eur J Pharm Biopharm; 2006 Oct; 64(2):200-5. PubMed ID: 16750355
[TBL] [Abstract][Full Text] [Related]
13. Characterization and stability of solid dispersions based on PEG/polymer blends.
Bley H; Fussnegger B; Bodmeier R
Int J Pharm; 2010 May; 390(2):165-73. PubMed ID: 20132875
[TBL] [Abstract][Full Text] [Related]
14. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: stability testing of selected solid dispersions.
Ghebremeskel AN; Vemavarapu C; Lodaya M
Pharm Res; 2006 Aug; 23(8):1928-36. PubMed ID: 16871443
[TBL] [Abstract][Full Text] [Related]
15. Physicochemical properties of tadalafil solid dispersions - Impact of polymer on the apparent solubility and dissolution rate of tadalafil.
Wlodarski K; Sawicki W; Haber K; Knapik J; Wojnarowska Z; Paluch M; Lepek P; Hawelek L; Tajber L
Eur J Pharm Biopharm; 2015 Aug; 94():106-15. PubMed ID: 25998701
[TBL] [Abstract][Full Text] [Related]
16. Dissolution rate of p-aminobenzoates from solid xylitol dispersions.
Sirenius I; Krogerus VE; Leppänen T
J Pharm Sci; 1979 Jun; 68(6):791-2. PubMed ID: 313436
[TBL] [Abstract][Full Text] [Related]
17. [Effect of stability and dissolution of realgar nano-particles using solid dispersion technology].
Guo T; Shi F; Yang G; Feng NP
Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(17):2782-7. PubMed ID: 24380298
[TBL] [Abstract][Full Text] [Related]
18. Unexpected differences in dissolution behavior of tablets prepared from solid dispersions with a surfactant physically mixed or incorporated.
de Waard H; Hinrichs WL; Visser MR; Bologna C; Frijlink HW
Int J Pharm; 2008 Feb; 349(1-2):66-73. PubMed ID: 17804180
[TBL] [Abstract][Full Text] [Related]
19. Atypical effects of incorporated surfactants on stability and dissolution properties of amorphous polymeric dispersions.
Al-Obaidi H; Lawrence MJ; Buckton G
J Pharm Pharmacol; 2016 Nov; 68(11):1373-1383. PubMed ID: 27696396
[TBL] [Abstract][Full Text] [Related]
20. Freeze-dried amorphous dispersions for solubility enhancement of thermosensitive API having low molecular lipophilicity.
Kulthe VV; Chaudhari PD; Aboul-Enein HY
Drug Res (Stuttg); 2014 Sep; 64(9):493-8. PubMed ID: 24443307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
